Sublingual Dexmedetomidine for Agitation in Bipolar Disorder, SARS-CoV-2 Infection and Maternal Morbidity and Mortality, Neurological Outcome in Refractory Out-of-Hospital Cardiac Arrest, and more
JAMA Editors' Summary · American Medical Association
February 22, 202213m 21s
Audio is streamed directly from the publisher (traffic.libsyn.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
Editor's Summary by Kristin Walter, MD, Associate Editor of JAMA, the Journal of the American Medical Association, for the February 22, 2022 issue.